← FDA DRUG APPROVALS

FDA ANDA · ANDA089835

METHYCLOTHIAZIDE

Sponsor: CHARTWELL RX

APPLICATION
ANDA089835
TYPE
ANDA
ORIGINAL APPROVAL
1988-08-18
LATEST ACTION
2001-05-09
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

METHYCLOTHIAZIDEDiscontinued
METHYCLOTHIAZIDE 2.5MG · TABLET · ORAL

Approval history

2001-05-09Manufacturing (CMC) · Supplement 3AP
1995-03-08Manufacturing (CMC) · Supplement 2AP
1992-02-14Labeling · Supplement 1AP
1988-08-18OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →